Fig. 1From: Cost-effectiveness of a whole-area testing pilot of asymptomatic SARS-CoV-2 infections with lateral flow devices: a modelling and economic analysis studyFlowchart of process for (a) estimating number of cases detected by mass testing that would not otherwise be detected and for (b) estimating number of cases prevented, and other healthcare outcomes. This process is followed iteratively for each day in the testing periodBack to article page